Relapse and non-relapse prediction using a sensitive circulating tumor DNA assay during colorectal cancer postoperative surveillance
Tomoko Sasaki, View ORCID ProfileTakeshi Iwaya, View ORCID ProfileMizunori Yaegashi, View ORCID ProfileMasashi Idogawa, View ORCID ProfileHayato Hiraki, Masakazu Abe, Yuka Koizumi, View ORCID ProfileNoriyuki Sasaki, View ORCID ProfileAkiko Yashima-Abo, Ryosuke Fujisawa, Fumitaka Endo, View ORCID ProfileShoichiro Tange, Tomomi Hirano, Koki Otsuka, Akira Sasaki, View ORCID ProfileMari Masuda, Masashi Fujita, View ORCID ProfileHidewaki Nakagawa, Fumiaki Takahashi, View ORCID ProfileYasushi Sasaki, View ORCID ProfileTakashi Tokino, View ORCID ProfileSatoshi S. Nishizuka
doi: https://doi.org/10.1101/2022.09.03.22279571
Tomoko Sasaki
1Department of Surgery, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
Takeshi Iwaya
2Department of Clinical Oncology, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
Mizunori Yaegashi
1Department of Surgery, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
Masashi Idogawa
3Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo, Japan
Hayato Hiraki
4Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Iwate, Japan
Masakazu Abe
4Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Iwate, Japan
5Department of Urology, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
Yuka Koizumi
1Department of Surgery, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
4Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Iwate, Japan
Noriyuki Sasaki
1Department of Surgery, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
4Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Iwate, Japan
Akiko Yashima-Abo
4Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Iwate, Japan
Ryosuke Fujisawa
1Department of Surgery, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
Fumitaka Endo
2Department of Clinical Oncology, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
Shoichiro Tange
3Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo, Japan
Tomomi Hirano
3Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo, Japan
Koki Otsuka
6Department of Surgery, Fujita health University School of Medicine, Toyoake, Aichi, Japan
Akira Sasaki
1Department of Surgery, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
Mari Masuda
7Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan
Masashi Fujita
8Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
Hidewaki Nakagawa
8Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
Fumiaki Takahashi
9Division of Medical Engineering, Department of Information Science, Iwate Medical University, Yahaba, Iwate, Japan
Yasushi Sasaki
3Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo, Japan
10Biology Division, Department of Liberal Arts and Sciences, Center for Medical Education, Sapporo Medical University, Sapporo, Japan
Takashi Tokino
3Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo, Japan
Satoshi S. Nishizuka
4Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Iwate, Japan
Posted September 06, 2022.
Relapse and non-relapse prediction using a sensitive circulating tumor DNA assay during colorectal cancer postoperative surveillance
Tomoko Sasaki, Takeshi Iwaya, Mizunori Yaegashi, Masashi Idogawa, Hayato Hiraki, Masakazu Abe, Yuka Koizumi, Noriyuki Sasaki, Akiko Yashima-Abo, Ryosuke Fujisawa, Fumitaka Endo, Shoichiro Tange, Tomomi Hirano, Koki Otsuka, Akira Sasaki, Mari Masuda, Masashi Fujita, Hidewaki Nakagawa, Fumiaki Takahashi, Yasushi Sasaki, Takashi Tokino, Satoshi S. Nishizuka
medRxiv 2022.09.03.22279571; doi: https://doi.org/10.1101/2022.09.03.22279571
Relapse and non-relapse prediction using a sensitive circulating tumor DNA assay during colorectal cancer postoperative surveillance
Tomoko Sasaki, Takeshi Iwaya, Mizunori Yaegashi, Masashi Idogawa, Hayato Hiraki, Masakazu Abe, Yuka Koizumi, Noriyuki Sasaki, Akiko Yashima-Abo, Ryosuke Fujisawa, Fumitaka Endo, Shoichiro Tange, Tomomi Hirano, Koki Otsuka, Akira Sasaki, Mari Masuda, Masashi Fujita, Hidewaki Nakagawa, Fumiaki Takahashi, Yasushi Sasaki, Takashi Tokino, Satoshi S. Nishizuka
medRxiv 2022.09.03.22279571; doi: https://doi.org/10.1101/2022.09.03.22279571
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (707)
- Anesthesia (198)
- Cardiovascular Medicine (2905)
- Dermatology (249)
- Emergency Medicine (435)
- Epidemiology (12674)
- Forensic Medicine (10)
- Gastroenterology (822)
- Genetic and Genomic Medicine (4530)
- Geriatric Medicine (411)
- Health Economics (722)
- Health Informatics (2895)
- Health Policy (1065)
- Hematology (382)
- HIV/AIDS (917)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4292)
- Nursing (233)
- Nutrition (630)
- Oncology (2249)
- Ophthalmology (639)
- Orthopedics (257)
- Otolaryngology (324)
- Pain Medicine (274)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1190)
- Primary Care Research (491)
- Public and Global Health (6877)
- Radiology and Imaging (1514)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (481)
- Toxicology (60)
- Transplantation (208)
- Urology (178)